Not that i was doing much in there anyway
GLP-1 drugs linked to lower risk for dementia in older adults with diabetes: Study A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by 23 to 44%, depending which medication they were on
doi: 10.1007/s10311-020-01038-1 12
This means that in the worst-case scenario when you lose weight using a GLP-1 agonist, the weight you lose when you weigh yourself is 50% from a loss of muscle mass and 50% from a loss of fat mass
A recently updated meta-analysis of four prospective cohort studies and two RCTs involving a total of 63 patients with psoriasis has shown that treatment with GLP-1RAs leads to significant reductions in disease severity, regardless of whether the patients have diabetes [210]
FMI's analysis of the GLP-1 receptor agonist market in Europe consists of country-wise assessment including Germany, United Kingdom, France, Italy, and Spain
